These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 9185705
21. Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation. Bonaccorsi L, Marchiani S, Muratori M, Forti G, Baldi E. J Cancer Res Clin Oncol; 2004 Oct; 130(10):604-14. PubMed ID: 15258753 [Abstract] [Full Text] [Related]
22. Transforming growth factor-alpha-mediated growth pathways in human gastro-intestinal cell lines in relation to the gastrin autocrine pathway. Watson SA, Robinson KE, McWilliams D, Michaeli D, Smith AM, Robinson G. Int J Cancer; 2000 Jul 01; 87(1):20-8. PubMed ID: 10861448 [Abstract] [Full Text] [Related]
23. P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation. Milenkovic I, Weick M, Wiedemann P, Reichenbach A, Bringmann A. Invest Ophthalmol Vis Sci; 2003 Mar 01; 44(3):1211-20. PubMed ID: 12601051 [Abstract] [Full Text] [Related]
24. Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo. Naruse I, Ohmori T, Ao Y, Fukumoto H, Kuroki T, Mori M, Saijo N, Nishio K. Int J Cancer; 2002 Mar 10; 98(2):310-5. PubMed ID: 11857424 [Abstract] [Full Text] [Related]
25. Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinoma. Nelson JM, Fry DW. Exp Cell Res; 1997 Jun 15; 233(2):383-90. PubMed ID: 9194500 [Abstract] [Full Text] [Related]
27. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Tyagi A, Agarwal R, Agarwal C. Oncogene; 2003 Mar 06; 22(9):1302-16. PubMed ID: 12618755 [Abstract] [Full Text] [Related]
29. Effects of anthralin and hypericin on growth factor signalling and cell proliferation in vitro. Richter A, Davies DE. Biochem Pharmacol; 1995 Dec 22; 50(12):2039-45. PubMed ID: 8849331 [Abstract] [Full Text] [Related]
31. Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation. Huynh H, Nguyen TT, Chan E, Tran E. Int J Oncol; 2003 Sep 22; 23(3):821-9. PubMed ID: 12888923 [Abstract] [Full Text] [Related]
32. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Siu SW, Lau KW, Tam PC, Shiu SY. Prostate; 2002 Jul 01; 52(2):106-22. PubMed ID: 12111702 [Abstract] [Full Text] [Related]
33. The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase. El-Zarruk AA, van den Berg HW. Cancer Lett; 1999 Aug 03; 142(2):185-93. PubMed ID: 10463775 [Abstract] [Full Text] [Related]
34. 4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase. Traxler PM, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N. J Med Chem; 1996 Jun 07; 39(12):2285-92. PubMed ID: 8691423 [Abstract] [Full Text] [Related]
38. Rapid stimulation of amyloid precursor protein release by epidermal growth factor: role of protein kinase C. Slack BE, Breu J, Muchnicki L, Wurtman RJ. Biochem J; 1997 Oct 01; 327 ( Pt 1)(Pt 1):245-9. PubMed ID: 9355759 [Abstract] [Full Text] [Related]